Clopixol Acuphase Injection 50 mg/ml is an antipsychotic drug sold under the brand name Clopixol. It is used to treat certain mental/psychiatric disorders such as schizophrenia, mania, and acute psychoses. It is a thioxanthene-derivative that has a strong action on dopamine receptors in the brain, which helps reduce mental disturbances and cognitive impairment related to mental illness.
Clopixol Acuphase Injection 50 mg/ml is used to treat certain psychiatric and mental illnesses, such as schizophrenia, mania, and acute psychoses. It can also be used to treat aggression, agitation, and other behavioral problems.
| Brand Name | Clopixol Acuphase |
|---|---|
| Type | Injection |
| Weight | 50 mg/ml |
| Generic | Zuclopenthixol |
| Manufacturer | Lundbeck Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Clopixol Acuphase Injection 50 mg/ml is a thioxanthene derivative that works by modulating presynaptic and postsynaptic dopamine receptor sites in the brain. This leads to a reduction in the psychotic and cognitive symptoms associated with mental illnesses.
The effects of Clopixol Acuphase Injection 50 mg/ml can vary depending on the individual. Generally, it can take up to a few weeks for the effects to be seen. It is important to continue to take this medication as prescribed by your doctor for the full duration of treatment, usually several weeks, in order to maximize its effectiveness.
Clopixol Acuphase Injection 50 mg/ml is well absorbed by the body and is quickly distributed into the bloodstream. The maximum plasma concentration is reached within 1-3 hours.
Clopixol Acuphase Injection 50 mg/ml is mainly excreted via the kidneys, with less than 5% of it being eliminated in the urine. A small portion of it is metabolized in the liver.
The recommended starting dose of Clopixol Acuphase Injection 50 mg/ml is 5-10mg per day. The dosage may be gradually increased, depending on the individual's response and clinical condition, up to a maximum daily dose of 40-50mg.
Clopixol Acuphase Injection 50 mg/ml is usually administered orally as tablets or liquid solution. It can also be administered as an intramuscular injection.
Common side effects of Clopixol Acuphase Injection 50 mg/ml include dry mouth, constipation, sleepiness, headache, dizziness, and weight gain. More serious side effects include an increased risk of stroke, seizures, and suicidal thoughts.
Clopixol Acuphase Injection 50 mg/ml is relatively safe when taken at prescribed doses. However, it can be toxic if taken in high doses, so it is important to follow the instructions of the prescribing doctor.
Interactions between Clopixol Acuphase Injection 50 mg/ml and certain other medications, such as anticoagulants and lithium, should be monitored closely, as they can lead to serious adverse reactions. It is also important to check for liver function before starting this medication.
Clopixol Acuphase Injection 50 mg/ml may interact with certain drugs, such as anticoagulants, lithium, and some antibiotics, leading to serious side effects. Therefore, caution is advised when taking Clopixol Acuphase Injection 50 mg/ml with these medications.
Patients with certain diseases, such as liver or kidney disease, should be monitored closely when taking Clopixol Acuphase Injection 50 mg/ml. It should also be used with caution in patients with epilepsy or cardiac conditions.
If taken with other medication, Clopixol Acuphase Injection 50 mg/ml may interact with them and cause serious side effects. Therefore, caution is advised when taking Clopixol Acuphase Injection 50 mg/ml with drugs such as anticoagulants, lithium, and certain antibiotics.
The effectiveness of Clopixol Acuphase Injection 50 mg/ml may be affected by certain foods, such as grapefruit, alcohol, and other citrus fruits. It is important to consult a doctor before eating these foods.
Clopixol Acuphase Injection 50 mg/ml should only be used during pregnancy if the benefits outweigh the risks. If being taken during pregnancy, it should be monitored closely.
Clopixol Acuphase Injection 50 mg/ml should be used with caution in women who are breastfeeding. It should not be used during breastfeeding unless the benefits outweigh the risks.
In case of an overdose of Clopixol Acuphase Injection 50 mg/ml, the patient should be monitored closely as it can lead to serious side effects. If overdose is suspected, medical help should be sought immediately.
Clopixol Acuphase Injection 50 mg/ml is contraindicated in patients who are hypersensitive to this drug or to any of its ingredients. It is also not recommended for patients with certain conditions, such as narrow-angle glaucoma, epilepsy, bone marrow suppression, and certain cardiac conditions.
Clopixol Acuphase Injection 50 mg/ml should be taken as prescribed by the doctor. It is important to take this medication exactly as prescribed, as it can lead to serious side effects or reduced effectiveness if it is taken in higher doses or for longer time periods than what is recommended.
Clopixol Acuphase Injection 50 mg/ml should be stored at room temperature, away from direct heat and light. It should also be kept away from children and pets.
The volume of distribution of Clopixol Acuphase Injection 50 mg/ml is estimated to be around 1.3 to 4.6 L/kg.
The elimination half-life of Clopixol Acuphase Injection 50 mg/ml is estimated to be around 20 to 30 hours.
The clearance of Clopixol Acuphase Injection 50 mg/ml is estimated to be around 52 to 77 L/h.
See in details version Clopixol Acuphase Injection 50 mg/ml also Clopixol Acuphase Injection 50 mg/ml in bangla
Dr. A.N.M Humayun Kabir
Orthopedics (Bone, Joint, Injury, Arthritis) Specialist & Trauma Surgeon